Promoters held 54.48 per cent stake in the company as of 30-Jun-2022, while FIIs owned 14.95 per cent, DIIs 19.67 per cent.

has buy call on with a target price of Rs 1074.1. The current market price of Sun Pharmaceutical Industries is Rs 923.15.

., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 217859.62 Crore) operating in Pharmaceuticals sector.

Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2022.

Financials
For the quarter ended 30-06-2022, the company reported a Consolidated Total Income of Rs 10763.90 Crore, up 12.59 % from last quarter Total Income of Rs 9560.35 Crore and up 9.04 % from last year same quarter Total Income of Rs 9871.26 Crore. Company reported net profit after tax of Rs 2095.85 Crore in latest quarter.

Promoter/FII Holdings
Promoters held 54.48 per cent stake in the company as of 30-Jun-2022, while FIIs owned 14.95 per cent, DIIs 19.67 per cent.

(Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.

Buy Sun Pharmaceutical Industries, target price Rs 1074.1: BNP Paribas

Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 217859.62 Crore) operating in Pharmaceuticals sector.

Read More News on